Easy Access and Express Report Delivery Service
Organoid Biobank Market, Global Outlook and Forecast 2023-2029
Report ID
35511
Publisher
Market Monitor Global
Published Date
17-Oct
Delivery Format
PDF
No of Report Page
100
Editor's Rating
-
Report Details
This research report provides a comprehensive analysis of the Organoid Biobank market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Organoid Biobank market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Organoid Biobank, challenges faced by the industry, and potential opportunities for market players. The global Organoid Biobank market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Organoid Biobank market presents opportunities for various stakeholders, including Biopharmaceutical Companies, Contract Research Organizations. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Organoid Biobank market. Additionally, the growing consumer demand present avenues for market expansion. The global Organoid Biobank market was valued at US$ 114.1 million in 2022 and is projected to reach US$ 386.8 million by 2029, at a CAGR of 19.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. The organoid biobank market is a growing field that encompasses the collection, storage, and distribution of human organoid models and biological samples required for a variety of medical and biological research. Key drivers of this market include increased demand for medical research, advances in organ transplantation and drug testing, developments in biotechnology, and the rise of personalized medicine. These biobanks provide researchers and pharmaceutical companies with important resources for disease research, drug screening, and personalized medicine, and therefore have huge potential and market opportunities in the fields of medicine and life sciences. Key Features: The research report on the Organoid Biobank market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders. Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Organoid Biobank market. Market Overview: The report provides a comprehensive overview of the Organoid Biobank market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Tissue Derived Organoids, Pluripotent Stem Cell-derived Organoids), region, and application, highlighting the key drivers, challenges, and opportunities within each segment. Market Dynamics: The report analyses the market dynamics driving the growth and development of the Organoid Biobank market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Organoid Biobank market's trajectory. Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Organoid Biobank market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments. Market Segmentation and Forecast: The report segment the Organoid Biobank market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions. Technological Trends: The report should highlight the key technological trends shaping the Organoid Biobank market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences. Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Organoid Biobank market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders. Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Organoid Biobank, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments. Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Organoid Biobank market. Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts. Market Segmentation Organoid Biobank market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value. Market segment by Type
- Tissue Derived Organoids
- Pluripotent Stem Cell-derived Organoids
- Biopharmaceutical Companies
- Contract Research Organizations
- Academics and Research Institutes
- US
- Canada
- Mexico
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- Brazil
- Argentina
- Rest of South America
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
- FRANKFURT CANCER INSTITUTE
- Merck
- Crown Bioscience
- HUB Organoids
- Cancer Research UK Convergence Science Centre
- Thermo Fisher Scientific
- Corning
- STEMCELL Technologies
- Lonza
- Prellis Biologics
- Amsbio
- Cellesce
- DefiniGEN
- 3Dnamics Inc.
- Organoid Therapeutics
- InSphero
- AIVITA Biomedical
- JangoBio
-
Table Of Content
1 Introduction to Research & Analysis Reports 1.1 Organoid Biobank Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Organoid Biobank Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process 1.5.3 Base Year 1.5.4 Report Assumptions & Caveats 2 Global Organoid Biobank Overall Market Size 2.1 Global Organoid Biobank Market Size: 2022 VS 2029 2.2 Global Organoid Biobank Market Size, Prospects & Forecasts: 2018-2029 2.3 Key Market Trends, Opportunity, Drivers and Restraints 2.3.1 Market Opportunities & Trends 2.3.2 Market Drivers 2.3.3 Market Restraints 3 Company Landscape 3.1 Top Organoid Biobank Players in Global Market 3.2 Top Global Organoid Biobank Companies Ranked by Revenue 3.3 Global Organoid Biobank Revenue by Companies 3.4 Top 3 and Top 5 Organoid Biobank Companies in Global Market, by Revenue in 2022 3.5 Global Companies Organoid Biobank Product Type 3.6 Tier 1, Tier 2 and Tier 3 Organoid Biobank Players in Global Market 3.6.1 List of Global Tier 1 Organoid Biobank Companies 3.6.2 List of Global Tier 2 and Tier 3 Organoid Biobank Companies 4 Market Sights by Product 4.1 Overview 4.1.1 By Type - Global Organoid Biobank Market Size Markets, 2022 & 2029 4.1.2 Tissue Derived Organoids 4.1.3 Pluripotent Stem Cell-derived Organoids 4.2 By Type - Global Organoid Biobank Revenue & Forecasts 4.2.1 By Type - Global Organoid Biobank Revenue, 2018-2023 4.2.2 By Type - Global Organoid Biobank Revenue, 2024-2029 4.2.3 By Type - Global Organoid Biobank Revenue Market Share, 2018-2029 5 Sights by Application 5.1 Overview 5.1.1 By Application - Global Organoid Biobank Market Size, 2022 & 2029 5.1.2 Biopharmaceutical Companies 5.1.3 Contract Research Organizations 5.1.4 Academics and Research Institutes 5.2 By Application - Global Organoid Biobank Revenue & Forecasts 5.2.1 By Application - Global Organoid Biobank Revenue, 2018-2023 5.2.2 By Application - Global Organoid Biobank Revenue, 2024-2029 5.2.3 By Application - Global Organoid Biobank Revenue Market Share, 2018-2029 6 Sights by Region 6.1 By Region - Global Organoid Biobank Market Size, 2022 & 2029 6.2 By Region - Global Organoid Biobank Revenue & Forecasts 6.2.1 By Region - Global Organoid Biobank Revenue, 2018-2023 6.2.2 By Region - Global Organoid Biobank Revenue, 2024-2029 6.2.3 By Region - Global Organoid Biobank Revenue Market Share, 2018-2029 6.3 North America 6.3.1 By Country - North America Organoid Biobank Revenue, 2018-2029 6.3.2 US Organoid Biobank Market Size, 2018-2029 6.3.3 Canada Organoid Biobank Market Size, 2018-2029 6.3.4 Mexico Organoid Biobank Market Size, 2018-2029 6.4 Europe 6.4.1 By Country - Europe Organoid Biobank Revenue, 2018-2029 6.4.2 Germany Organoid Biobank Market Size, 2018-2029 6.4.3 France Organoid Biobank Market Size, 2018-2029 6.4.4 U.K. Organoid Biobank Market Size, 2018-2029 6.4.5 Italy Organoid Biobank Market Size, 2018-2029 6.4.6 Russia Organoid Biobank Market Size, 2018-2029 6.4.7 Nordic Countries Organoid Biobank Market Size, 2018-2029 6.4.8 Benelux Organoid Biobank Market Size, 2018-2029 6.5 Asia 6.5.1 By Region - Asia Organoid Biobank Revenue, 2018-2029 6.5.2 China Organoid Biobank Market Size, 2018-2029 6.5.3 Japan Organoid Biobank Market Size, 2018-2029 6.5.4 South Korea Organoid Biobank Market Size, 2018-2029 6.5.5 Southeast Asia Organoid Biobank Market Size, 2018-2029 6.5.6 India Organoid Biobank Market Size, 2018-2029 6.6 South America 6.6.1 By Country - South America Organoid Biobank Revenue, 2018-2029 6.6.2 Brazil Organoid Biobank Market Size, 2018-2029 6.6.3 Argentina Organoid Biobank Market Size, 2018-2029 6.7 Middle East & Africa 6.7.1 By Country - Middle East & Africa Organoid Biobank Revenue, 2018-2029 6.7.2 Turkey Organoid Biobank Market Size, 2018-2029 6.7.3 Israel Organoid Biobank Market Size, 2018-2029 6.7.4 Saudi Arabia Organoid Biobank Market Size, 2018-2029 6.7.5 UAE Organoid Biobank Market Size, 2018-2029 7 Organoid Biobank Companies Profiles 7.1 FRANKFURT CANCER INSTITUTE 7.1.1 FRANKFURT CANCER INSTITUTE Company Summary 7.1.2 FRANKFURT CANCER INSTITUTE Business Overview 7.1.3 FRANKFURT CANCER INSTITUTE Organoid Biobank Major Product Offerings 7.1.4 FRANKFURT CANCER INSTITUTE Organoid Biobank Revenue in Global Market (2018-2023) 7.1.5 FRANKFURT CANCER INSTITUTE Key News & Latest Developments 7.2 Merck 7.2.1 Merck Company Summary 7.2.2 Merck Business Overview 7.2.3 Merck Organoid Biobank Major Product Offerings 7.2.4 Merck Organoid Biobank Revenue in Global Market (2018-2023) 7.2.5 Merck Key News & Latest Developments 7.3 Crown Bioscience 7.3.1 Crown Bioscience Company Summary 7.3.2 Crown Bioscience Business Overview 7.3.3 Crown Bioscience Organoid Biobank Major Product Offerings 7.3.4 Crown Bioscience Organoid Biobank Revenue in Global Market (2018-2023) 7.3.5 Crown Bioscience Key News & Latest Developments 7.4 HUB Organoids 7.4.1 HUB Organoids Company Summary 7.4.2 HUB Organoids Business Overview 7.4.3 HUB Organoids Organoid Biobank Major Product Offerings 7.4.4 HUB Organoids Organoid Biobank Revenue in Global Market (2018-2023) 7.4.5 HUB Organoids Key News & Latest Developments 7.5 Cancer Research UK Convergence Science Centre 7.5.1 Cancer Research UK Convergence Science Centre Company Summary 7.5.2 Cancer Research UK Convergence Science Centre Business Overview 7.5.3 Cancer Research UK Convergence Science Centre Organoid Biobank Major Product Offerings 7.5.4 Cancer Research UK Convergence Science Centre Organoid Biobank Revenue in Global Market (2018-2023) 7.5.5 Cancer Research UK Convergence Science Centre Key News & Latest Developments 7.6 Thermo Fisher Scientific 7.6.1 Thermo Fisher Scientific Company Summary 7.6.2 Thermo Fisher Scientific Business Overview 7.6.3 Thermo Fisher Scientific Organoid Biobank Major Product Offerings 7.6.4 Thermo Fisher Scientific Organoid Biobank Revenue in Global Market (2018-2023) 7.6.5 Thermo Fisher Scientific Key News & Latest Developments 7.7 Corning 7.7.1 Corning Company Summary 7.7.2 Corning Business Overview 7.7.3 Corning Organoid Biobank Major Product Offerings 7.7.4 Corning Organoid Biobank Revenue in Global Market (2018-2023) 7.7.5 Corning Key News & Latest Developments 7.8 STEMCELL Technologies 7.8.1 STEMCELL Technologies Company Summary 7.8.2 STEMCELL Technologies Business Overview 7.8.3 STEMCELL Technologies Organoid Biobank Major Product Offerings 7.8.4 STEMCELL Technologies Organoid Biobank Revenue in Global Market (2018-2023) 7.8.5 STEMCELL Technologies Key News & Latest Developments 7.9 Lonza 7.9.1 Lonza Company Summary 7.9.2 Lonza Business Overview 7.9.3 Lonza Organoid Biobank Major Product Offerings 7.9.4 Lonza Organoid Biobank Revenue in Global Market (2018-2023) 7.9.5 Lonza Key News & Latest Developments 7.10 Prellis Biologics 7.10.1 Prellis Biologics Company Summary 7.10.2 Prellis Biologics Business Overview 7.10.3 Prellis Biologics Organoid Biobank Major Product Offerings 7.10.4 Prellis Biologics Organoid Biobank Revenue in Global Market (2018-2023) 7.10.5 Prellis Biologics Key News & Latest Developments 7.11 Amsbio 7.11.1 Amsbio Company Summary 7.11.2 Amsbio Business Overview 7.11.3 Amsbio Organoid Biobank Major Product Offerings 7.11.4 Amsbio Organoid Biobank Revenue in Global Market (2018-2023) 7.11.5 Amsbio Key News & Latest Developments 7.12 Cellesce 7.12.1 Cellesce Company Summary 7.12.2 Cellesce Business Overview 7.12.3 Cellesce Organoid Biobank Major Product Offerings 7.12.4 Cellesce Organoid Biobank Revenue in Global Market (2018-2023) 7.12.5 Cellesce Key News & Latest Developments 7.13 DefiniGEN 7.13.1 DefiniGEN Company Summary 7.13.2 DefiniGEN Business Overview 7.13.3 DefiniGEN Organoid Biobank Major Product Offerings 7.13.4 DefiniGEN Organoid Biobank Revenue in Global Market (2018-2023) 7.13.5 DefiniGEN Key News & Latest Developments 7.14 3Dnamics Inc. 7.14.1 3Dnamics Inc. Company Summary 7.14.2 3Dnamics Inc. Business Overview 7.14.3 3Dnamics Inc. Organoid Biobank Major Product Offerings 7.14.4 3Dnamics Inc. Organoid Biobank Revenue in Global Market (2018-2023) 7.14.5 3Dnamics Inc. Key News & Latest Developments 7.15 Organoid Therapeutics 7.15.1 Organoid Therapeutics Company Summary 7.15.2 Organoid Therapeutics Business Overview 7.15.3 Organoid Therapeutics Organoid Biobank Major Product Offerings 7.15.4 Organoid Therapeutics Organoid Biobank Revenue in Global Market (2018-2023) 7.15.5 Organoid Therapeutics Key News & Latest Developments 7.16 InSphero 7.16.1 InSphero Company Summary 7.16.2 InSphero Business Overview 7.16.3 InSphero Organoid Biobank Major Product Offerings 7.16.4 InSphero Organoid Biobank Revenue in Global Market (2018-2023) 7.16.5 InSphero Key News & Latest Developments 7.17 AIVITA Biomedical 7.17.1 AIVITA Biomedical Company Summary 7.17.2 AIVITA Biomedical Business Overview 7.17.3 AIVITA Biomedical Organoid Biobank Major Product Offerings 7.17.4 AIVITA Biomedical Organoid Biobank Revenue in Global Market (2018-2023) 7.17.5 AIVITA Biomedical Key News & Latest Developments 7.18 JangoBio 7.18.1 JangoBio Company Summary 7.18.2 JangoBio Business Overview 7.18.3 JangoBio Organoid Biobank Major Product Offerings 7.18.4 JangoBio Organoid Biobank Revenue in Global Market (2018-2023) 7.18.5 JangoBio Key News & Latest Developments 8 Conclusion 9 Appendix 9.1 Note 9.2 Examples of Clients 9.3 Disclaimer
-
Inquiry Before Buying
WHY CHOOSE US
Discover Business Growth OpportunitiesMore than 10 Years Experience Employee SupportIn-depth and Comprehensive Analysis100+ Client Queries Handled Everyday -
Request Sample
WHY CHOOSE US
Easy Access and Express Report Delivery ServiceDiscover Business Growth OpportunitiesMore than 10 Years Experience Employee SupportIn-depth and Comprehensive Analysis100+ Client Queries Handled Everyday
